Loading...
PhD Stanislav Gobec

PhD Stanislav Gobec
no.: 15284 source: ARIS

researcher – active in research organisation
Phone number (01) 476 95 00
E-mail stanislav.gobecat signffa.uni-lj.si
Foreign language skills
Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   
Keywords
Medicinal chemistry, drug design, analysis and syntehesis, peptydomimetics, phosphorous analogs of amino acids and peptides
Points
1,955.44
A''
306.47
A'
1,156.8
A1/2
1,617.15
CI10
5,473
CImax
362
h10
39
A1
7.05
A3
2.69
Data for the last 5 years (citations for the last 10 years) on July 24, 2024; A3 for period 2018-2022 (update for tender in 2023: YES)
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Database Linked records Citations Pure citations Average pure citations
WoS 275  6,981  5,901  21.46 
Scopus 283  7,475  6,314  22.31 
Mentoring junior researchers
source: ARIS
no. Name and surname Type Period Code
1 PhD Anže Meden  Bologna doctoral studies  10/1/2019 - 9/30/2023  53584 
2 PhD Katarina Grabrijan  Bologna doctoral studies  10/1/2018 - 9/30/2022  50814 
3 PhD Eva Shannon Schiffrer  Bologna doctoral studies  10/1/2016 - 2/5/2021  39200 
4 PhD Kaja Rožman  Bologna doctoral studies  12/1/2014 - 6/6/2018  37050 
5 PhD Damijan Knez  Bologna doctoral studies  10/1/2013 - 3/31/2017  36438 
6 PhD Urban Košak  Bologna doctoral studies  12/1/2012 - 7/5/2016  33908 
7 PhD Boris Brus  Bologna doctoral studies  12/1/2011 - 3/31/2015  34508 
8 PhD Martina Hrast Rambaher  Bologna doctoral studies  10/1/2009 - 4/5/2013  32036 
9 PhD Izidor Sosič  Bologna doctoral studies  10/1/2008 - 3/31/2012  30816 
10 PhD Matej Živec  Uniform doctoral studies  11/1/2005 - 4/30/2010  26493 
11 PhD Matej Sova  Doctoral degree  10/1/2004 - 3/31/2009  25490 
12 PhD Jan Humljan  Uniform doctoral studies  1/1/2003 - 8/31/2005  23599 
13 PhD Katja Štrancar  Doctoral degree  11/1/2000 - 10/31/2004  21458 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
    Pharmacy  SI 1994 
Doctor's degree  Ph. D.   Pharmacy  SI University of Ljubljana, Faculty of Pharmacy 1999 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Role Title
Full time employment (120%, RD:70%)  University of Ljubljana, Faculty of Pharmacy  Chair for Pharmaceutical Chemistry  11/15/1994    Researcher  Full professor 
Research projects Legend
source: ARIS
no. Code Title Period Head No. of publications
1. J3-50123  Bacterial Biofilm Formation Inhibitors: A Novel Approach to Combat Antimicrobial Resistance   2023 - 2024  PhD Martina Hrast Rambaher  2,248 
2. J1-50039  Breaking the Walls: Development of Inhibitors of D,D- and L,D-Transpeptidases   2023 - 2024  PhD Stanislav Gobec  3,811 
3. N1-0277  Research of multifunctional compounds targeting neuroinflammation and cholinergic deficit in Alzheimer's disease   2023 - 2024  PhD Stanislav Gobec  1,081 
4. J1-4417  Development of novel small molecule Toll-like receptors 7 and 8 modulators for cancer immunotherapy   2022 - 2024  PhD Matej Sova  3,973 
5. J1-4400  Evaluation of transient protein states   2022 - 2024  PhD Simona Golič Grdadolnik  3,284 
6. J1-4414  ProBiS-Fold approach for binding site detection for whole structural human proteome in drug discovery   2022 - 2024  PhD Dušanka Janežič  2,088 
7. J3-3071  Cathepsins B and X in breast cancer stem cells – molecular targets and relevance for antitumor therapy   2021 - 2024  PhD Ana Mitrović  2,688 
8. L1-3160  Development of highly concentrated protein formulations and evaluation of absorption kinetics after subcutaneous administration   2021 - 2024  PhD Iztok Grabnar  2,982 
9. J1-3018  Smart probes for ex vivo assay-based early prediction of Alzheimer disease   2021 - 2024  PhD Janez Košmrlj  2,240 
10. N1-0169  Kovalentni pristop k boju proti bakterijski rezistenci (Slovene)   2021 - 2023  PhD Stanislav Gobec  1,206 
11. J1-2484  Development of antibacterial compounds targeting validated enzymes in peptidoglycan biosynthesis   2020 - 2023  PhD Stanislav Gobec  3,921 
12. J4-1778  Exploitation of a virus-borne small protein to combat antibiotic resistance in Staphylococcus aureus   2019 - 2022  PhD Matej Butala  3,429 
13. J4-1776  Improvement of immunotherapeutic potential of NK cells through modulation of cystatin F   2019 - 2022  PhD Janko Kos  2,972 
14. J1-1715  Protein interaction atlas for prediction of genetic variations involved in drug interactions and disease development   2019 - 2022  PhD Dušanka Janežič  2,595 
15. J3-9267  Inhibition of cathepsin X activity as a novel strategy for the treatment of Parkinson's disease   2018 - 2021  PhD Anja Pišlar  2,767 
16. NC-0009  Development of new carbamate-based imaging probes for cholinesterases   2019 - 2021  PhD Stanislav Gobec  1,073 
17. N1-0068  Identification of non-peptidic inhibitors of the immunoproteasome using fragment based drug discovery methods   2017 - 2020  PhD Stanislav Gobec  1,855 
18. J4-8227  Cathepsin X inhibitors impair the resistence of tumor cells to antiprotease therapy   2017 - 2020  PhD Janko Kos  4,608 
19. L1-8157  Development of multifunctional compounds for treatment of Alzheimer's disease   2017 - 2020  PhD Stanislav Gobec  4,756 
20. J1-8145  Dynamic aspect of ligand-protein binding   2017 - 2020  PhD Simona Golič Grdadolnik  1,795 
21. J1-7515  Receptors for toxins of plant pathogens   2016 - 2018  PhD Gregor Anderluh  3,887 
22. J1-7479  Structural insight into iodine metabolism   2016 - 2018  PhD Dušan Turk  1,789 
23. L1-6745  Combating bacterial resistance: optimisation of bacterial cell wall biosynthesis inhibitors   2014 - 2017  PhD Stanislav Gobec  3,275 
24. J1-6743  Computational tools development for modeling of pharmaceutically interesting molecules   2014 - 2017  PhD Dušanka Janežič  2,756 
25. J4-6811  The role of cysteine protease inhibitors in NK cell mediated lysis of tumour cells   2014 - 2017  PhD Janko Kos  2,471 
26. J4-5529  Nitroxoline and its derivatives as new antitumour drugs   2013 - 2016  PhD Janko Kos  6,006 
27. L1-4039  Preclinical development of new antibacterial drugs   2011 - 2014  PhD Stanislav Gobec  4,202 
28. J4-2212  Glivni citokromi P450, vključeni v detoksifikacijo rastlinskih obramnih spojin, kot tarče novih protiglivnih učinkovin (Slovene)   2009 - 2012  PhD Nada Kraševec  3,768 
29. J4-4123  Inhibitors of cysteine carboxypeptidases as regulators of autoimmune and neurodegenerative processes   2011  PhD Janko Kos  6,383 
30. L3-5084  Peptidominetiki - inhibitorji koagulacije krvi in agregacije trombocitov (Slovene)   2003 - 2005  PhD Mojca Stegnar  5,576 
31. L1-0469  Optimization of MDP and TNF analogues having therapeutic potential   1998 - 2000  PhD Anton Štalc  6,273 
ARIS research and infrastructure programmes Legend
source: ARIS
International projects
no. Code Title Period Head No. of publications
1. HORIZON-BREAKthrough-241087  Breaking the barrier - An integrated multidisciplinary approach to kill Gram-negative bacteria through existing antibiotics by making their outer membrane permeable   1/1/2023 - 12/31/2026     
2. FP7-HEALTH-ORCHID-96802  Open Collaborative Model for Tuberculosis Lead Optimisation   1/1/2011 - 6/30/2015  Stanislav Gobec   
3. FP6-LIFESCIHEALTH-EUR-INTAFAR-74098  Inhibition of new targets for fighting antibiotic resistance   1/1/2005 - 6/30/2010  Stanislav Gobec   
Views history
Favourite